Navigation Links
Phase Genomics and Phyzen Co., Ltd. Announce Korean Distribution Partnership
Date:4/11/2017

Today, Phase Genomics and Phyzen Co., Ltd. have announced an exclusive partnership to deliver Phase Genomics’ Proximo™ Hi-C genome scaffolding service to the Korean market. The deal makes Phyzen the sole distributor of the service in all of South Korea.

“Phyzen’s experience and expertise in the Korean market will be a tremendous asset for further expanding our ability to deliver Proximo Hi-C to scientists and researchers around the world,” said Ivan Liachko, Phase Genomics’ co-founder and CEO. “With this partnership, biological research in South Korea is poised to make significant leaps forward.”

The Proximo Hi-C service builds on Hi-C-based genome scaffolding technology invented by members of the Phase Genomics founding team in 2013. Proximo has been used on hundreds of genome assemblies to date, including a goat genome recently published in Nature Genetics and highlighted in The Atlantic. This goat genome represents the most contiguous mammalian de novo assembly ever constructed, and the company notes many of its other customers are preparing manuscripts of their own on numerous plants and animals assembled with Proximo Hi-C.

“We have been impressed by the unparalleled capabilities of Phase Genomics’ Proximo Hi-C since we first saw its results,” said Kyoung-Dae Kang, CEO of Phyzen. “This technology will be of great importance to the Korean scientific community, and we’re thrilled to partner with Phase Genomics to be the exclusive providers of this service in South Korea.”

South Korean researchers may now contact Phyzen via their website to obtain more information about how to access Proximo Hi-C services. General information as well as instructions for obtaining the service outside South Korea can be found on Phase Genomics’ website.

ABOUT PHASE GENOMICS - Phase Genomics, Inc. is based in Seattle, WA and was founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs. The company’s mission is to empower researchers of all kinds with state-of-the-art genomic tools. The company serves academic and commercial researchers in diverse fields and industries.

Website: http://www.phasegenomics.com
Contact: info(at)phasegenomics(dot)com

ABOUT PHYZEN CO. LTD. - Phyzen Co., Ltd. is a bioinformatics and genomics service provider based in Seongnam, South Korea. The company was founded in 2013 by a team of genome scientists, bioinformaticians, and entrepreneurs. Phyzen closely works together with diverse researchers in university, government institute and private sector to provide the better solutions in genome research.

Website: http://www.phyzen.com
Contact: info(at)phyzen(dot)com

Read the full story at http://www.prweb.com/releases/2017/04/prweb14225455.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
2. Self-assembled nanostructures enable a low-power phase-change memory for mobile electronic devices
3. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
4. Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma
5. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
6. irisnote Announces Successful Conclusion of Beta Test Phase
7. Risk Assessment and Mitigation in Phase I Trials in High Risk Compounds: A Continuously Developing Process, new life science webinar hosted by Xtalks
8. Trigemina Receives ISP Approval of Clinical Study Protocol for TI-001 Phase 2 Trial
9. Inflamax Research Chosen to Conduct a Multicenter Environmental Exposure Chamber Phase 3 Study of Ultrashort Grass Allergy Vaccine by Allergy Therapeutics (UK) Ltd.
10. St. Mary Completes Phase 2 of Its Emergency Department and Trauma Center Expansion
11. Gene Therapy Developed for ALS Treatment: New Biotech Company Neuralgene Enters Evaluation Phase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... ... a basic first aid supply for any work environment, but most personal eye wash can ... a dangerous substance enters both eyes? It’s one less decision, and likely quicker response time ... , “Whether its dirt and debris, or an acid or alkali, getting anything in your ...
(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
(Date:10/11/2017)... Austin, TX (PRWEB) , ... October 11, 2017 ... ... in August compared the implantation and pregnancy rates in frozen and fresh ... the contribution of progesterone and maternal age to IVF success. , After comparing ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
Breaking Biology Technology:
(Date:10/4/2017)... , Oct. 4, 2017  GCE Solutions, a global clinical ... data and document anonymization solution on October 4, 2017. Shadow is ... field to comply with policy 0070 of the European Medicines Agency ... data. ... GCE Solutions ...
(Date:7/20/2017)... Delta (NYSE: DAL ) customers now can use ... Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan Washington ... Delta,s biometric boarding pass experience that ... integrated into the boarding process to allow eligible Delta SkyMiles Members who ...
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at ... between startups and global businesses, taking place in ... startups will showcase the solutions they have built with IBM ... France is one of the most ... increase in the number of startups created between 2012 and ...
Breaking Biology News(10 mins):